Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/19/2014WO2014091430A1 Pharmaceutical composition comprising a meglitinide and a thiazolidinedione, and use thereof
06/19/2014WO2014091420A1 Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
06/19/2014WO2014091415A1 Indole carboxamide derivatives as p2x7 receptor antagonists
06/19/2014WO2014091352A1 Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
06/19/2014WO2014091318A1 Reduced dose pharmaceutical compositions of fenofibrate
06/19/2014WO2014091308A1 5-aminosalicylic acid capsule formulation
06/19/2014WO2014091298A2 Nitrogen containing morphinan derivatives and the use thereof
06/19/2014WO2014091297A1 Spirocyclic morphinans and their use
06/19/2014WO2014091295A1 Pyridonemorphinan analogs and biological activity on opioid receptors
06/19/2014WO2014091268A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
06/19/2014WO2014091265A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors
06/19/2014WO2014091263A1 Telmisartan containing pharmaceutical composition
06/19/2014WO2014091241A1 Chlorin derivative useful in photodynamic therapy and diagnosis
06/19/2014WO2014091239A1 Novel pharmaceutical formulations and their use in the treatment of periodontal disease
06/19/2014WO2014091138A1 Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
06/19/2014WO2014091134A1 Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
06/19/2014WO2014091078A1 Polymeric particles-based temozolomide dosage form
06/19/2014WO2014091046A1 Versatile and functionalised intermediates for the synthesis of vitamin d and novel vitamin d derivatives
06/19/2014WO2014091020A1 Phenanthrene derivatives for use as medicaments
06/19/2014WO2014090991A1 Medicament for atrophy treatment or increasing cell growth
06/19/2014WO2014090990A1 Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease
06/19/2014WO2014090985A1 T-cell modulation by exon skipping
06/19/2014WO2014090976A1 Copper intrauterine device
06/19/2014WO2014090929A1 Compositions comprising vortioxetine and donepezil
06/19/2014WO2014090921A1 Transdermal delivery system
06/19/2014WO2014090889A1 Oral solutions comprising folic acid
06/19/2014WO2014090875A1 Combination of ethambutol with at least one additional anti-bacterial agent for use in the treatment of bacterial infections
06/19/2014WO2014090859A1 Gel compositions
06/19/2014WO2014090858A1 Gel compositions
06/19/2014WO2014090857A1 Gel compositions
06/19/2014WO2014090855A1 Gel compositions
06/19/2014WO2014090842A1 Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine
06/19/2014WO2014090832A1 Tannin derivative and pharmaceutical compositions comprising said tannin derivative
06/19/2014WO2014090731A1 New positive allosteric modulators of nicotinic acetylcholine receptor
06/19/2014WO2014090715A1 Thiazole derivatives as inhibitors of bruton's tyrosine kinase
06/19/2014WO2014090712A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/19/2014WO2014090710A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/19/2014WO2014090709A1 Dimeric compounds
06/19/2014WO2014090700A1 Malononitrile compounds for controlling animal pests
06/19/2014WO2014090586A1 Delphinidin for combating melanoma cells
06/19/2014WO2014090583A1 Delphinidin for combating melanoma cells
06/19/2014WO2014090546A1 Compositions for oral use containing collagen and elastin hydrolysates and vitamin c, which promote the deposit of extracellular matrix
06/19/2014WO2014090398A1 Use of maleimide derivatives for preventing and treating leukemia
06/19/2014WO2014090396A2 Use of maleimide derivatives for preventing and treating cancer
06/19/2014WO2014090386A1 Orally disintegrating tablet containing asenapine
06/19/2014WO2014090306A1 Artemisinin and its derivatives for use in the treatment of kidney disease
06/19/2014WO2014090293A1 Preparations
06/19/2014WO2014090259A1 Product comprising red clover extract and methods for producing the same
06/19/2014WO2014090174A1 Nanoscale capecitabine and preparation method therefor
06/19/2014WO2014090173A1 Nanoscale doxorubicin hydrochloride and preparation method therefor
06/19/2014WO2014090171A1 Nanoscale cyclophosphamide and preparation method thereof
06/19/2014WO2014090169A1 Nanoscale paclitaxel and preparation method thereof
06/19/2014WO2014090168A1 Nanoscale docetaxel and preparation method thereof
06/19/2014WO2014090151A1 New application of catalpol
06/19/2014WO2014090147A1 Pyrimidine derivatives and salts thereof, preparation method and pharmaceutical use thereof
06/19/2014WO2014090128A1 Arteannuin cyclodextrin conjugate and preparing method thereof
06/19/2014WO2014090127A1 Cyclodextrin carrier-based arteannuin compound conjugate and preparing method thereof
06/19/2014WO2014089957A1 Stable busulfan injection
06/19/2014WO2014089913A1 Bicyclic compound functioning as tyrosine kinase inhibitor
06/19/2014WO2014089904A1 Triazinone compounds
06/19/2014WO2014089649A1 Nanofibres containing controlled release active substance for odontological application and method
06/19/2014WO2014089646A1 Use of products from paullinia cupana to prevent or treat hot flushes
06/19/2014WO2014089620A1 Compositions and method for maintaining/improving cognitive function
06/19/2014WO2014080422A3 Pyridone derivatives as acid secretion inhibitors and process for preparation thereof
06/19/2014WO2014077712A8 Solid lipid nanoparticles of roxithromycin for hair loss or acne
06/19/2014WO2014064711A3 Methods of administering raltegravir and raltegravir compositions
06/19/2014WO2014064191A3 Drug combinations containing statins for treating cardiovascular diseases
06/19/2014WO2014063107A3 Stable peracid-containing compositions
06/19/2014WO2014063054A8 Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
06/19/2014WO2014062852A3 Thiohydantoin derivatives and uses thereof
06/19/2014WO2014062811A3 METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2
06/19/2014WO2014062720A3 Methods of treating cancer
06/19/2014WO2014059238A3 Modulation of androgen receptor expression
06/19/2014WO2014056623A3 Tyrosinase inhibitors for depigmentation or hair removal
06/19/2014WO2014055996A3 Rho kinase inhibitors
06/19/2014WO2014049609A3 Novel salts of vilazodone
06/19/2014WO2014039526A3 Carbamate compounds and methods of use in diseases of the nervous system
06/19/2014WO2014039515A3 Antifungal agents and uses thereof
06/19/2014WO2014036105A3 Inhibitors of memapsin 2 cleavage for the treatment of alzheimer's disease
06/19/2014WO2014016849A3 Novel triazine compounds
06/19/2014WO2013158814A8 Immediate release, abuse deterrent pharmaceutical compositions
06/19/2014WO2013134353A8 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
06/19/2014WO2013126146A3 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
06/19/2014US20140172118 Bioactive Compositions, Bioactive Eluting Devices and Methods of Use Thereof
06/19/2014US20140171918 Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
06/19/2014US20140171674 Nutritional compositions comprising high oleic acid canola oil
06/19/2014US20140171516 Geranylgeranylacetone formulations
06/19/2014US20140171515 Compositions and methods for transmucosal absorption
06/19/2014US20140171514 Nmda receptor antagonist formulation with reduced neurotoxicity
06/19/2014US20140171511 Cough Reducing Product
06/19/2014US20140171509 Non-Aqueous Patch
06/19/2014US20140171508 Method of treating parkinson's disease comprising administering deferoxamine (dfo) to the upper one-third of the nasal cavity
06/19/2014US20140171506 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
06/19/2014US20140171505 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
06/19/2014US20140171504 Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
06/19/2014US20140171502 New Process
06/19/2014US20140171500 Health promoting drink
06/19/2014US20140171499 Pseudopolymorphic Forms Of A HIV Protease Inhibitor
06/19/2014US20140171497 Animal supplements and compositions containing soluable monensin and methods therefor
06/19/2014US20140171496 Composition and method for promoting hair growth
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 7860